Erez Meltzer Acquires 36,000 Shares of Nano-X Imaging (NASDAQ:NNOX) Stock

Nano-X Imaging Ltd. (NASDAQ:NNOX) CEO Erez Meltzer purchased 36,000 shares of the company’s stock in a transaction that occurred on Monday, July 27th. The shares were purchased at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the purchase, the chief executive officer owned 36,000 shares in the company, valued at $33,480. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Nano-X Imaging Stock Performance

Shares of Nano-X Imaging stock opened at $0.88 on Thursday. Nano-X Imaging Ltd. has a 52 week low of $0.73 and a 52 week high of $5.08. The stock has a 50 day moving average price of $1.45 and a two-hundred day moving average price of $2.06. The stock has a market capitalization of $61.05 million, a PE ratio of -0.56 and a beta of 1.24.

Nano-X Imaging (NASDAQ:NNOX) last released its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. Research analysts forecast that Nano-X Imaging Ltd. will post -0.6 EPS for the current year.

Trending Headlines about Nano-X Imaging

Here are the key news stories impacting Nano-X Imaging this week:

• Positive Sentiment: CEO Erez Meltzer purchased 36,000 NNOX shares at an average price of $0.93, investing approximately $33,480. Director Dan S. Suesskind also bought 50,000 shares at the same average price, signaling that insiders may view the depressed valuation as attractive. However, the purchases are relatively small compared with the company’s broader financial and legal risks. CEO insider purchase filing Director insider purchase filing
• Neutral Sentiment: Rosen, Levi & Korsinsky, Faruqi & Faruqi and other firms reminded investors of the August 11 deadline to seek lead-plaintiff status. These notices are largely legal-firm solicitations rather than new operating developments, but their frequency increases visibility around the litigation. Rosen deadline notice Levi and Korsinsky deadline notice
• Negative Sentiment: The class action filed against Nano-X and certain officers alleges that the company failed to disclose rising cash burn and operating expenses before recording a $17.5 million impairment and undertaking manufacturing restructuring. The allegations relate to shares purchased between March 31, 2025 and April 17, 2026, and have not been proven in court. Potential legal costs, reputational damage and uncertainty over the company’s finances are weighing on NNOX. Pomerantz class action announcement

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on NNOX. Zacks Research upgraded shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a research report on Wednesday, July 8th. Alliance Global Partners downgraded Nano-X Imaging from a “buy” rating to a “neutral” rating and cut their price target for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, D. Boral Capital reissued a “buy” rating and set a $5.00 price objective on shares of Nano-X Imaging in a report on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $4.00.

Institutional Trading of Nano-X Imaging

Several institutional investors have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Nano-X Imaging by 8.4% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company’s stock valued at $182,000 after purchasing an additional 2,724 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in Nano-X Imaging by 20.5% during the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock worth $116,000 after purchasing an additional 3,818 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in Nano-X Imaging by 62.1% during the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after purchasing an additional 5,283 shares during the last quarter. BNP Paribas Financial Markets grew its position in Nano-X Imaging by 64.6% in the 3rd quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after purchasing an additional 7,749 shares in the last quarter. Finally, Mariner LLC increased its stake in Nano-X Imaging by 70.5% in the 4th quarter. Mariner LLC now owns 20,825 shares of the company’s stock valued at $58,000 after buying an additional 8,614 shares during the last quarter. Institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.